维普期刊资源整合服务平台（V6.5）

25篇 您的检索式：作者名="Dayspring"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Ezetimibe therapy: mechanism of action and clinical update显示文摘	Phan BA Dayspring TD Toth PP	2012	Vasc Health Risk Manag2012，8，2：	1
2	Impact of triglycerides on lipid and lipoprotein biology in women显示文摘	Thomas D. Dayspring Gregory Pokrywka	2010	Gender Medicine2010，，3：	1
3	Impact of triglycerides onlipid and lipoprotein biology in women显示文摘	DAYSPRING T D POKRYWKA G	2010	Gend Med2010，7，3：	1
4	Drug therapy for hyper- triglyceridemia: fibrates and omega-3 fatty acids显示文摘	Toth PP Dayspring TD Pokrywka GS	2009	Curr Ather- oscler Rep2009，11，1：	1
5	Drug safety evaluation of rosuvastatin 显示文摘	Toth PP Dayspring TD	2011	Expert Opin Drug Saf2011，10，6：	1
6	Drug safety evaluation of rosuvastatin显示文摘	Toth PP Dayspring TD		0，，06：	1
7	Drug safety evaluation of rosuvastatin显示文摘	Toth PP Dayspring TD	2011	Expert Opin Drug Saf2011，10，6：	1
8	Impact of triglycefides on lipid and lipo- protein biology in women 显示文摘	Dayspring TD Porkrywka G	2010	Gend Me2010，7，3：	1
9	Impact of triglycerides on lipid and lipoprotein biology in women 显示文摘	Dayspring TD Pokrywka G	2010	Gend Med2010，7，3：	1
10	Impact of triglycerides on lipid and lipoprotein biology in women显示文摘	DAYSPRING T D POKRYWKA G	2010	Gender Medicine2010，7，3：	1
11	Lipo- protein(a) mass: a massively misunderstood metric显示文摘	Mcconnell JP Guadagno PA Dayspring TD	2014	J Clin Lipidol2014，8，6：	1
12	Ezetimibe therapy: mechanism of action and clinical update显示文摘	Peter Toth Thomas Dayspring Phan	2012	Vascular Health and Risk Management . 2012 (defa)2012，，：	1
13	Drug safety evaluation of rosuvastatin 显示文摘	Toth PP Dayspring TD	2011	Expert Opin Drug Saf2011，10，6：	1
14	Impact of triglycerides on lipid and lipo- protein biology in women 显示文摘	Dayspring TD Pokrywka G	2010	Gend M ed2010，7，3：	1
15	Effects of raloxifene on lipid and lipo- protein levels in postmenopausal osteoporotic women with and without hypertriglyceridemia显示文摘	Dayspring T Qu Y Keech C	2006	Metabolism2006，55，7：	1
16	Ezetimibe therapy : mechanism of action and clinical update显示文摘	Phan BA Dayspring TD Toth PP	2012	Vasc Health Risk Manag2012，，8：	1
17	Drug safety evaluation of rosuv- astatin显示文摘	Toth PP Dayspring TD	2011	Expert Opin Drug Saf2011，10，6：	1
18	Ezetimibe therapy : mechanism of action and clinical update 显示文摘	Phan BA Dayspring TD Toth PP	2012	Vasc Health Risk Manag2012，8，：	1
19	Discordance between Apolipoprotein B and Low-density Lipoprotein Particle Number is Associated with Insulin Resistance in Clinical Practice显示文摘	Stephen A. Varvel Thomas D. Dayspring Yvette Edmonds Dawn L. Thiselton Leila Ghaedi Szilard Voros Joseph P. McConnell Maciek Sasinowski Tara Dall G. Russell Warnick	2014	Journal of Clinical Lipidology2014，，：	1
20	Drug safety evaluation of rosuvastatin 显示文摘	Toth PP Dayspring TD	2011	Expert Opin Drug Saf2011，10，6：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示